铁蛋白沉积介导 LPS 诱导的急性肺损伤中气道上皮 E-cadherin 功能障碍

IF 3.3 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Zemin Chen , Haixiong Tang , Sudan Gan , Changyun Yang , Shiyue Li , Jing Li , Lihong Yao
{"title":"铁蛋白沉积介导 LPS 诱导的急性肺损伤中气道上皮 E-cadherin 功能障碍","authors":"Zemin Chen ,&nbsp;Haixiong Tang ,&nbsp;Sudan Gan ,&nbsp;Changyun Yang ,&nbsp;Shiyue Li ,&nbsp;Jing Li ,&nbsp;Lihong Yao","doi":"10.1016/j.pupt.2023.102284","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Loss of E-cadherin in the airway epithelial cells is a critical contributor to the development of ALI/ARDS. Yet the underlying mechanisms are largely unknown. Increasing evidences have revealed the significance of ferroptosis in the pathophysiological process of ALI/ARDS. The aim of this study was to investigate the role of ferroptosis in dysregulation of airway epithelial E-cadherin in ALI/ARDS.</p></div><div><h3>Methods</h3><p><span>BALB/c mice were subjected to intratracheal instillation of </span>lipopolysaccharide<span><span> (LPS) to establish an ALI model. Two inhibitors of ferroptosis, liproxstatin-1 (Lip-1, at the dose of 10 mg/kg and 30 mg/kg) and ferrostatin-1 (Fer-1, at the dose of 1 mg/kg and 5 mg/kg), were respectively given to the mice through </span>intraperitoneal injection after LPS challenge. The expression of ferroptotic markers, full-length E-cadherin and soluble E-cadherin (sE-cadherin) were both detected.</span></p></div><div><h3>Results</h3><p>LPS exposure dramatically down-regulated pulmonary expression of E-cadherin in mice, with profound loss of membrane E-cadherin in the airway epithelial cells and increased secretion of sE-cadherin in the airway lumen. At the same time, we found that the mitochondrial of airway epithelial cells in LPS-exposed mice exhibited significant morphological alterations that are hallmark features of ferroptosis, with smaller volume and increased membrane density. Other makers of ferroptosis were also detected, including increased cytoplasmic levels of iron and lipid peroxidates (MDA), as well as decreased GPX4 expression. 30 mg/kg of Lip-1 not only showed potent protective effects against the LPS-induced injury, inflammation, edema of the lung in those mice, but also rescued airway epithelial E-cadherin expression and decreased the release of sE-cadherin through inhibiting ferroptosis. While no noticeable changes induced by LPS were observed in mice treated with Lip-1 at 10 mg/kg nor Fer-1 at 1 mg/kg or 5 mg/kg.</p></div><div><h3>Conclusions</h3><p>Taken together, these data demonstrated that ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced ALI.</p></div>","PeriodicalId":20799,"journal":{"name":"Pulmonary pharmacology & therapeutics","volume":"84 ","pages":"Article 102284"},"PeriodicalIF":3.3000,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced acute lung injury\",\"authors\":\"Zemin Chen ,&nbsp;Haixiong Tang ,&nbsp;Sudan Gan ,&nbsp;Changyun Yang ,&nbsp;Shiyue Li ,&nbsp;Jing Li ,&nbsp;Lihong Yao\",\"doi\":\"10.1016/j.pupt.2023.102284\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Loss of E-cadherin in the airway epithelial cells is a critical contributor to the development of ALI/ARDS. Yet the underlying mechanisms are largely unknown. Increasing evidences have revealed the significance of ferroptosis in the pathophysiological process of ALI/ARDS. The aim of this study was to investigate the role of ferroptosis in dysregulation of airway epithelial E-cadherin in ALI/ARDS.</p></div><div><h3>Methods</h3><p><span>BALB/c mice were subjected to intratracheal instillation of </span>lipopolysaccharide<span><span> (LPS) to establish an ALI model. Two inhibitors of ferroptosis, liproxstatin-1 (Lip-1, at the dose of 10 mg/kg and 30 mg/kg) and ferrostatin-1 (Fer-1, at the dose of 1 mg/kg and 5 mg/kg), were respectively given to the mice through </span>intraperitoneal injection after LPS challenge. The expression of ferroptotic markers, full-length E-cadherin and soluble E-cadherin (sE-cadherin) were both detected.</span></p></div><div><h3>Results</h3><p>LPS exposure dramatically down-regulated pulmonary expression of E-cadherin in mice, with profound loss of membrane E-cadherin in the airway epithelial cells and increased secretion of sE-cadherin in the airway lumen. At the same time, we found that the mitochondrial of airway epithelial cells in LPS-exposed mice exhibited significant morphological alterations that are hallmark features of ferroptosis, with smaller volume and increased membrane density. Other makers of ferroptosis were also detected, including increased cytoplasmic levels of iron and lipid peroxidates (MDA), as well as decreased GPX4 expression. 30 mg/kg of Lip-1 not only showed potent protective effects against the LPS-induced injury, inflammation, edema of the lung in those mice, but also rescued airway epithelial E-cadherin expression and decreased the release of sE-cadherin through inhibiting ferroptosis. While no noticeable changes induced by LPS were observed in mice treated with Lip-1 at 10 mg/kg nor Fer-1 at 1 mg/kg or 5 mg/kg.</p></div><div><h3>Conclusions</h3><p>Taken together, these data demonstrated that ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced ALI.</p></div>\",\"PeriodicalId\":20799,\"journal\":{\"name\":\"Pulmonary pharmacology & therapeutics\",\"volume\":\"84 \",\"pages\":\"Article 102284\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-12-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pulmonary pharmacology & therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1094553923000962\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonary pharmacology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094553923000962","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:气道上皮细胞中 E-cadherin 的缺失是导致 ALI/ARDS 的关键因素。然而,其潜在机制在很大程度上还不为人所知。越来越多的证据揭示了铁凋亡在 ALI/ARDS 病理生理过程中的重要性。本研究旨在探究铁蜕变在 ALI/ARDS 中气道上皮 E-cadherin 失调中的作用:方法:对 BALB/c 小鼠进行气管内灌注脂多糖(LPS)以建立 ALI 模型。方法:对BALB/c小鼠进行气管内灌注脂多糖(LPS)以建立ALI模型,并在LPS挑战后分别给小鼠腹腔注射两种铁氧化酶抑制剂--脂氧司他丁-1(Lip-1,剂量为10毫克/千克和30毫克/千克)和铁前列素-1(Fer-1,剂量为1毫克/千克和5毫克/千克)。结果发现,LPS暴露显著降低了小鼠肺部铁蛋白的表达:结果:LPS暴露显著下调了小鼠肺部E-cadherin的表达,气道上皮细胞膜E-cadherin大量丢失,气道腔内sE-cadherin分泌增加。同时,我们发现暴露于 LPS 的小鼠气道上皮细胞的线粒体表现出明显的形态学改变,体积变小,膜密度增加,这是铁蛋白沉积症的标志性特征。此外,还检测到了其他铁变态反应的制造者,包括细胞质中铁和脂质过氧化物(MDA)水平的升高,以及 GPX4 表达的降低。30 毫克/千克的 Lip-1 不仅对 LPS 诱导的小鼠肺损伤、炎症和水肿有很强的保护作用,而且还能通过抑制铁变态反应来挽救气道上皮 E-cadherin 的表达和减少 sE-cadherin 的释放。而用 10 毫克/千克的 Lip-1 或 1 毫克/千克或 5 毫克/千克的 Fer-1 处理小鼠时,未观察到 LPS 引起的明显变化:总之,这些数据表明,在 LPS 诱导的 ALI 中,铁跃迁介导了气道上皮 E-cadherin 功能障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced acute lung injury

Background

Loss of E-cadherin in the airway epithelial cells is a critical contributor to the development of ALI/ARDS. Yet the underlying mechanisms are largely unknown. Increasing evidences have revealed the significance of ferroptosis in the pathophysiological process of ALI/ARDS. The aim of this study was to investigate the role of ferroptosis in dysregulation of airway epithelial E-cadherin in ALI/ARDS.

Methods

BALB/c mice were subjected to intratracheal instillation of lipopolysaccharide (LPS) to establish an ALI model. Two inhibitors of ferroptosis, liproxstatin-1 (Lip-1, at the dose of 10 mg/kg and 30 mg/kg) and ferrostatin-1 (Fer-1, at the dose of 1 mg/kg and 5 mg/kg), were respectively given to the mice through intraperitoneal injection after LPS challenge. The expression of ferroptotic markers, full-length E-cadherin and soluble E-cadherin (sE-cadherin) were both detected.

Results

LPS exposure dramatically down-regulated pulmonary expression of E-cadherin in mice, with profound loss of membrane E-cadherin in the airway epithelial cells and increased secretion of sE-cadherin in the airway lumen. At the same time, we found that the mitochondrial of airway epithelial cells in LPS-exposed mice exhibited significant morphological alterations that are hallmark features of ferroptosis, with smaller volume and increased membrane density. Other makers of ferroptosis were also detected, including increased cytoplasmic levels of iron and lipid peroxidates (MDA), as well as decreased GPX4 expression. 30 mg/kg of Lip-1 not only showed potent protective effects against the LPS-induced injury, inflammation, edema of the lung in those mice, but also rescued airway epithelial E-cadherin expression and decreased the release of sE-cadherin through inhibiting ferroptosis. While no noticeable changes induced by LPS were observed in mice treated with Lip-1 at 10 mg/kg nor Fer-1 at 1 mg/kg or 5 mg/kg.

Conclusions

Taken together, these data demonstrated that ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced ALI.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
41
审稿时长
42 days
期刊介绍: Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews. Research Areas Include: • All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary Toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信